Drugs / GENEVAX IL-12-4532
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00775424 | Sep 2008 → Jun 2010 | HIV infectious disease | University of Pennsylvania | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GENEVAX IL-12-4532 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00775424 ↗ |
| Modality | Other / unclassified | “GENEVAX IL-12-4532 This molecular adjuvant plasmid contains nucleotide sequences necessary for expression of the human IL-12 protein.” NCT00775424 ↗ |